
Enveric Biosciences, Inc.
ENVBHealthcare|Biotechnology|US
$1.42
+0.00 (+0.28%)
DCF Value
$12.40
Tangible Book / Share
$2.03
Cash / Share
$2.08
Next Earnings Report
Nov 12, 2026
Financing Filings (last 12 months)
11
Shelf registrations / offering prospectuses — latest Jun 9, 2026 (424B5). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
Enveric Biosciences Reports Differentiated Brain Activity Profile for EB-003 in Preclinical qEEG Study
Nov 4, 2026 · Business Wire
Enveric Biosciences Announces Positive Results from Recently Completed IND-enabling ADMET Studies
Oct 21, 2026 · Business Wire
Enveric Biosciences Secures New U.S. Patent Allowance for Next-Generation, Non-Hallucinogenic Mescaline Derivatives in EVM401 Series
Sep 15, 2026 · Business Wire
Enveric Biosciences to Present at H.C. Wainwright 28th Annual Global Investment Conference
Sep 1, 2026 · Business Wire
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Second Quarter 2026
Aug 14, 2026 · Business Wire
SEC Filings (110)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 3, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Aug 14, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 14, 2026 | 8-K | Material event | DocumentIndex |
| Aug 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 14, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Aug 13, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jun 9, 2026 | 8-K | Material event | DocumentIndex |
| Jun 9, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Jun 9, 2026 | 8-K | Material event | DocumentIndex |
| Jun 1, 2026 | S-8 | Employee stock plan | DocumentIndex |
| May 29, 2026 | 8-K | Material event | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 15, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 15, 2026 | 8-K | Material event | DocumentIndex |
| May 4, 2026 | D | DocumentIndex | |
| Apr 30, 2026 | 8-K | Material event | DocumentIndex |
| Apr 30, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 29, 2026 | EFFECT | DocumentIndex | |
| Apr 29, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Apr 23, 2026 | S-3 | Shelf registration | DocumentIndex |
| Apr 20, 2026 | 8-K | Material event | DocumentIndex |
| Apr 14, 2026 | ARS | Annual report to holders | DocumentIndex |
| Apr 14, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 14, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 3, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Mar 27, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 27, 2026 | 8-K | Material event | DocumentIndex |
| Feb 18, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Feb 17, 2026 | EFFECT | DocumentIndex | |
| Feb 11, 2026 | D | DocumentIndex | |
| Feb 10, 2026 | S-1 | IPO / offering registration | DocumentIndex |
| Feb 6, 2026 | 8-K | Material event | DocumentIndex |
| Feb 6, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Feb 4, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Feb 2, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jan 28, 2026 | 8-K | Material event | DocumentIndex |
| Jan 28, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Jan 9, 2026 | 8-K | Material event | DocumentIndex |
| Jan 5, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Dec 31, 2025 | 424B3 | Offering prospectus | DocumentIndex |